Clinical Trial Update: Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating bevacizumab plus fractionated stereotactic radiotherapy (FSRT) versus hippocampus-avoidant whole-brain radiotherapy in brai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lung Adenocarcinoma, Brain Metastases | Phase 3 | Status: RECRUITING